Jawaher Ansari

814 total citations
38 papers, 487 citations indexed

About

Jawaher Ansari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jawaher Ansari has authored 38 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Surgery. Recurrent topics in Jawaher Ansari's work include Renal cell carcinoma treatment (8 papers), Cancer Genomics and Diagnostics (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Jawaher Ansari is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Cancer Genomics and Diagnostics (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Jawaher Ansari collaborates with scholars based in United Kingdom, United Arab Emirates and Saudi Arabia. Jawaher Ansari's co-authors include David I. Min, Robert Naraghi, T. Shah, Syed A. Hussain, Arwa Ali, Jean‐Marc Nabholtz, Nicholas D. James, D. Rea, D. Palmer and Indrajit Fernando and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jawaher Ansari

36 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jawaher Ansari United Kingdom 15 202 184 136 75 63 38 487
Mei Kong China 11 127 0.6× 129 0.7× 185 1.4× 99 1.3× 75 1.2× 30 436
A. Chiara Italy 17 163 0.8× 132 0.7× 158 1.2× 100 1.3× 109 1.7× 47 684
Thomas B. Russell United States 7 335 1.7× 146 0.8× 115 0.8× 177 2.4× 75 1.2× 17 577
Yongmei Liu China 14 174 0.9× 336 1.8× 178 1.3× 42 0.6× 84 1.3× 31 684
Yasunori Yoshimoto Japan 13 199 1.0× 100 0.5× 209 1.5× 47 0.6× 118 1.9× 39 547
Yanli Hou China 10 234 1.2× 143 0.8× 135 1.0× 43 0.6× 74 1.2× 24 537
Alec Kacew United States 12 157 0.8× 60 0.3× 99 0.7× 46 0.6× 76 1.2× 25 400
Carolyn Nessim Canada 15 306 1.5× 141 0.8× 169 1.2× 118 1.6× 71 1.1× 51 571
Aruni Ghose United Kingdom 14 451 2.2× 214 1.2× 307 2.3× 168 2.2× 76 1.2× 61 886
Krisztina Bogos Hungary 13 336 1.7× 208 1.1× 267 2.0× 128 1.7× 52 0.8× 37 675

Countries citing papers authored by Jawaher Ansari

Since Specialization
Citations

This map shows the geographic impact of Jawaher Ansari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jawaher Ansari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jawaher Ansari more than expected).

Fields of papers citing papers by Jawaher Ansari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jawaher Ansari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jawaher Ansari. The network helps show where Jawaher Ansari may publish in the future.

Co-authorship network of co-authors of Jawaher Ansari

This figure shows the co-authorship network connecting the top 25 collaborators of Jawaher Ansari. A scholar is included among the top collaborators of Jawaher Ansari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jawaher Ansari. Jawaher Ansari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giridharan, Selvaraj & Jawaher Ansari. (2024). Efficacy and Safety of Laughter Yoga in Cancer Patients: A Scoping Review of Randomized Controlled Trials. Cureus. 16(4). e59163–e59163.
2.
Ansari, Jawaher, et al.. (2024). Clinical Outcomes and Treatment Efficacy in Cervical Cancer Patients in the UAE: A Retrospective Cohort Study. Cureus. 16(7). e64422–e64422. 1 indexed citations
3.
Ameri, Mouza Al, et al.. (2024). Oncotype DX in Breast Cancer Management: Insights and Outcomes From the United Arab Emirates. Cureus. 16(3). e56535–e56535. 1 indexed citations
4.
Jazieh, Abdul Rahman, Hikmat Abdel‐Razeq, Jawaher Ansari, et al.. (2024). Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR). SHILAP Revista de lepidopterología. 7(2). 82–88. 1 indexed citations
5.
Shash, Emad, Layth Mula‐Hussain, Zineb Benbrahim, et al.. (2022). Prevalence and Risk Factors of Burnout Among Female Oncologists From the Middle East and North Africa. Frontiers in Psychology. 13. 845024–845024. 4 indexed citations
6.
Jazieh, Abdul Rahman, et al.. (2020). Management guidelines for stage III non-small cell lung cancer. Critical Reviews in Oncology/Hematology. 157. 103144–103144. 19 indexed citations
7.
Alsaleh, Khalid, Arwa Ali, Jawaher Ansari, et al.. (2017). Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy. Oncology Letters. 14(1). 337–344. 30 indexed citations
8.
Hussain, Syed A., Daniel H. Palmer, Wing‐Kin Syn, et al.. (2017). Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology. 50(4). 1147–1159. 21 indexed citations
9.
10.
Ali, Arwa, et al.. (2016). Triple Negative Breast Cancer: A Tale of Two Decades. Anti-Cancer Agents in Medicinal Chemistry. 17(4). 491–499. 36 indexed citations
11.
12.
Shah, T., et al.. (2015). Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients. Transplantation Proceedings. 47(2). 394–398. 71 indexed citations
13.
Shah, T., Jawaher Ansari, Prashant Sakharkar, et al.. (2014). Interferon‐gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients. Transplant Infectious Disease. 16(5). 724–732. 14 indexed citations
14.
Nyholm, Tufve, Joakim Jönsson, Karin Söderström, et al.. (2013). Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study. Radiation Oncology. 8(1). 126–126. 37 indexed citations
15.
Venugopal, Balaji, et al.. (2013). Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma. BMC Urology. 13(1). 26–26. 13 indexed citations
16.
Payne, Heather, et al.. (2012). Chemotherapy for bladder cancer: an update. Trends in Urology & Men s Health. 3(6). 37–40. 1 indexed citations
17.
Ansari, Jawaher, et al.. (2011). Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions. Anti-Cancer Agents in Medicinal Chemistry. 11(3). 296–306. 4 indexed citations
18.
Kovačević, Ana, Jawaher Ansari, & Petri Mähönen. (2010). NanoSD: A Flexible Service Discovery Protocol for Dynamic and Heterogeneous Wireless Sensor Networks. 14–19. 10 indexed citations
19.
Ansari, Jawaher, D. Palmer, D. Rea, & Syed A. Hussain. (2009). Role of Tyrosine Kinase Inhibitors in Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry. 9(5). 569–575. 25 indexed citations
20.
Ansari, Jawaher, Alan Doherty, Ian McCafferty, et al.. (2009). Neoadjuvant Sunitinib Facilitates Nephron-Sparing Surgery and Avoids Long-Term Dialysis in a Patient With Metachronous Contralateral Renal Cell Carcinoma. Clinical Genitourinary Cancer. 7(2). E39–E41. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Kong Breakdown of academic impact, for papers by A. Chiara Breakdown of academic impact, for papers by Thomas B. Russell Breakdown of academic impact, for papers by Yongmei Liu Breakdown of academic impact, for papers by Yasunori Yoshimoto Breakdown of academic impact, for papers by Yanli Hou Breakdown of academic impact, for papers by Alec Kacew Breakdown of academic impact, for papers by Carolyn Nessim Breakdown of academic impact, for papers by Aruni Ghose Breakdown of academic impact, for papers by Krisztina Bogos
Rankless by CCL
2026